Skip to main content
Top
Published in: Endocrine 3/2018

01-06-2018 | Research Letter

Brown tumors of primary hyperparathyroidism may be a source of extrarenal 1,25-dihydroxyvitamin D production

Authors: Melissa Sum, Dean Larner, Martin Hewison, John P. Bilezikian

Published in: Endocrine | Issue 3/2018

Login to get access

Excerpt

Primary hyperparathyroidism (PHPT) is classically characterized by hypercalcemia and an elevated or inappropriately normal parathyroid hormone (PTH) concentration. Associated biochemical indices include a serum phosphorus concentration in the lower range of normal [1], total alkaline phosphatase activity in the upper range of normal [2], low 25-hydroxyvitamin D (25(OH)D) levels [3], and 1,25-dihydroxyvitamin D (1,25(OH)2D) levels that are in the upper range of normal or frankly elevated [4]. PTH facilitates the 1α-hydroxylase enzymatic conversion of 25(OH)D to 1,25(OH)2D, a property that helps to account for the classic depiction of 25(OH)D and 1,25(OH)2D D levels in PHPT [5]. Other diseases associated with overproduction of 1,25(OH)2D include sarcoidosis and tuberculosis in which macrophages in the associated granulomas have acquired the 1α-hydroxylase activity. In lymphomas as well, 1,25(OH)2D-mediated hypercalcemia has been shown to be associated with abnormal synthesis of 1,25(OH)2D by macrophages in the lymphomatous tissue [6]. Today, in parts of the world where calcium is measured routinely, most patients with PHPT lack the overt renal and skeletal manifestations of PHPT which include osteitis fibrosa cystica, a skeletal feature of PHPT characterized by marked radiographic demineralization, fibrosis, brown tumors, and cysts. Histologically, the brown tumors consist of giant cells and fibroblastic stroma. The presentation of such bone lesions is now considered to be an unusual manifestation of PHPT in countries where asymptomatic PHPT has become the predominant presentation of the disease. Thus, the elevated 1,25(OH)2D level in the usual form of PHPT seen today is appropriately assumed to be of renal origin. However, in the case of PHPT associated with brown tumors, it is possible that the macrophages contained therein could contribute to excessive extrarenal production of 1,25(OH)2D levels. …
Literature
1.
go back to reference S.J. Silverberg, J.P. Bilezikian. Asymptomatic Primary Hyperparathyroidism. The Parathyroids, ed. by J.P. Bilezikian (Elsevier, San Diego, 2015) S.J. Silverberg, J.P. Bilezikian. Asymptomatic Primary Hyperparathyroidism. The Parathyroids, ed. by J.P. Bilezikian (Elsevier, San Diego, 2015)
2.
go back to reference A.G. Costa, C. Marcocci, J.P. Bilezikian. Bone Turnover Markers in Primary Hyperparathyroidism. The Parathyroids, ed. by J.P. BilezikianElsevier, San Diego, 2015) A.G. Costa, C. Marcocci, J.P. Bilezikian. Bone Turnover Markers in Primary Hyperparathyroidism. The Parathyroids, ed. by J.P. BilezikianElsevier, San Diego, 2015)
3.
go back to reference S.J. Silverberg, Vitamin D deficiency and primary hyperparathyroidism. J. Bone Miner. Res. 22(2), 100–104 (2007)CrossRef S.J. Silverberg, Vitamin D deficiency and primary hyperparathyroidism. J. Bone Miner. Res. 22(2), 100–104 (2007)CrossRef
4.
go back to reference S.J. Silverberg, E. Shane, T.P. Jacobs, E. Siris, J.P. Bilezikian, A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N. Engl. J. Med. 341(17), 1249–1255 (1999)CrossRefPubMed S.J. Silverberg, E. Shane, T.P. Jacobs, E. Siris, J.P. Bilezikian, A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N. Engl. J. Med. 341(17), 1249–1255 (1999)CrossRefPubMed
5.
go back to reference J. Bollerslev, L. Rolighed, L. Mosekilde, Mild primary hyperparathyroidism and metabolism of vitamin D. IBMS Bone 8(7), 342–351 (2011)CrossRef J. Bollerslev, L. Rolighed, L. Mosekilde, Mild primary hyperparathyroidism and metabolism of vitamin D. IBMS Bone 8(7), 342–351 (2011)CrossRef
6.
go back to reference M. Hewison, V. Kantorovich, H.R. Liker, A.J. Van Herle, P. Cohan, D. Zehnder, J.S. Adams, Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J. Bone Miner. Res. 18(3), 579–582 (2003)CrossRefPubMed M. Hewison, V. Kantorovich, H.R. Liker, A.J. Van Herle, P. Cohan, D. Zehnder, J.S. Adams, Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J. Bone Miner. Res. 18(3), 579–582 (2003)CrossRefPubMed
7.
go back to reference B. Moosgaard, P. Vestergaard, L. Heickendorff, L. Mosekilde, Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function. Clin. Endocrinol. 66(1), 35–42 (2007)CrossRef B. Moosgaard, P. Vestergaard, L. Heickendorff, L. Mosekilde, Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function. Clin. Endocrinol. 66(1), 35–42 (2007)CrossRef
8.
go back to reference S.J. Silverberg, J.P. Bilezikian. Primary hyperparathyroidism. Oxford Textbook of Endocrinology and Diabetes, ed. by J.A.H. Wass, P.M. Stewart (Oxford University Press, Oxford, England, 2011) S.J. Silverberg, J.P. Bilezikian. Primary hyperparathyroidism. Oxford Textbook of Endocrinology and Diabetes, ed. by J.A.H. Wass, P.M. Stewart (Oxford University Press, Oxford, England, 2011)
9.
go back to reference L. Aghaghazvini, H. Sharifian, B. Rasuli, Primary hyperparathyroidism misdiagnosed as giant cell bone tumor of maxillary sinus: a case report. Iran. J. Radiol. 13(1), e13260 (2016)CrossRefPubMedPubMedCentral L. Aghaghazvini, H. Sharifian, B. Rasuli, Primary hyperparathyroidism misdiagnosed as giant cell bone tumor of maxillary sinus: a case report. Iran. J. Radiol. 13(1), e13260 (2016)CrossRefPubMedPubMedCentral
10.
go back to reference E. Ullah, M. Ahmad, S.A. Ali, N. Redhu, Primary hyperparathyroidism having multiple Brown tumors mimicking malignancy. Indian J. Endocrinol. Metab. 16(6), 1040–1042 (2012)CrossRefPubMedPubMedCentral E. Ullah, M. Ahmad, S.A. Ali, N. Redhu, Primary hyperparathyroidism having multiple Brown tumors mimicking malignancy. Indian J. Endocrinol. Metab. 16(6), 1040–1042 (2012)CrossRefPubMedPubMedCentral
11.
go back to reference L. Vera, M. Dolcino, M. Mora, S. Oddo, M. Gualco, F. Minuto, M. Giusti, Primary hyperparathyroidism diagnosed after surgical ablation of a costal mass mistaken for giant-cell bone tumor: a case report. J. Med. Case Rep. 5, 596 (2011)CrossRefPubMedPubMedCentral L. Vera, M. Dolcino, M. Mora, S. Oddo, M. Gualco, F. Minuto, M. Giusti, Primary hyperparathyroidism diagnosed after surgical ablation of a costal mass mistaken for giant-cell bone tumor: a case report. J. Med. Case Rep. 5, 596 (2011)CrossRefPubMedPubMedCentral
12.
go back to reference J.L. Males, W.J. Howard, D.R. Mask, J.L. Townsend, J.B. Snow, H.T. McPherson, Primary hyperparathyroidism presenting as a giant cell tumor of the maxilla. Arch. Intern. Med. 132(1), 107–111 (1973)CrossRefPubMed J.L. Males, W.J. Howard, D.R. Mask, J.L. Townsend, J.B. Snow, H.T. McPherson, Primary hyperparathyroidism presenting as a giant cell tumor of the maxilla. Arch. Intern. Med. 132(1), 107–111 (1973)CrossRefPubMed
13.
go back to reference R. Eastell, M.L. Brandi, A.G. Costa, P. D’Amour, D.M. Shoback, R.V. Thakker, Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workship. J. Clin. Endocrinol. Metab. 99(10), 3570–3579 (2014)CrossRefPubMed R. Eastell, M.L. Brandi, A.G. Costa, P. D’Amour, D.M. Shoback, R.V. Thakker, Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workship. J. Clin. Endocrinol. Metab. 99(10), 3570–3579 (2014)CrossRefPubMed
14.
go back to reference B. Moosgaard, S.E. Christensen, P. Vestergaard, L. Heickendorff, P. Christiansen, L. Mosekilde, Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin. Endocrinol. 68(5), 707–715 (2008)CrossRef B. Moosgaard, S.E. Christensen, P. Vestergaard, L. Heickendorff, P. Christiansen, L. Mosekilde, Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin. Endocrinol. 68(5), 707–715 (2008)CrossRef
Metadata
Title
Brown tumors of primary hyperparathyroidism may be a source of extrarenal 1,25-dihydroxyvitamin D production
Authors
Melissa Sum
Dean Larner
Martin Hewison
John P. Bilezikian
Publication date
01-06-2018
Publisher
Springer US
Published in
Endocrine / Issue 3/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1579-3

Other articles of this Issue 3/2018

Endocrine 3/2018 Go to the issue